PFIZER INC. is poised to penetrate the lucrative market for treating asthma and chronic obstructive pulmonary disease COPD, with not just one, but two promising drugs, generating industry buzz. Its copromotional drug Spiriva tiotropium recently PFIZER INC. is poised to penetrate the lucrative market...
Nippon Boehringer Ingelheim and Pfizer Japan jointly announced that they have launched SpiNet, a website for information on Spiriva, an ethical drug used in the treatment of chronic obstructive pulmonary disease COPD.
BOEHRINGER INGELHEIM AND PFIZER are hitting the lanes with new creative for their Spiriva COPD medication. TV and print ads, by Ogilvy & Mather, feature COPD sufferers holding up placards extolling the benefits of treatment. The drug competes with GSK's Advair and could soon face Schering-Plough and Novartis' Asmanex/Foradil combo....
Another month has passed so it's time once again to look at the pharmaceutical news that didn't deserve a headline but was still too strange to be ignored. Here are BNET's 10 Weirdest Drug Stories of October 2008: Malaria cure is now cherry flavored Novartis has...
Beat the crowds and save big on their favorite sports gear! Shop today
